Aquaporin-4 Protein

Overview

Aquaporin-4 (AQP4) is the principal water channel in the brain, highly expressed in astrocyte end-feet that surround cerebral blood vessels and in ependymal cells lining the ventricles^{1AQP4 in brain (2003)2003 · PMID 12665610Open reference}. AQP4 plays a critical role in glymphatic clearance—a brain-wide waste clearance system that removes metabolic byproducts, toxic proteins, and interstitial solutes during sleep^{2Glymphatic clearance of Aβ (2012)2012 · DOI 10.1126/science.1220363Open reference}. Dysregulation of AQP4 has been implicated in Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, traumatic brain injury (TBI), and multiple sclerosis (MS)^{3Papadopoulos & Verkman, AQP4 in brain disorders (2013)2013 · DOI 10.1038/nrm3520Open reference4AQP4 in Parkinson's disease (2018)2018 · PMID 29526542Open reference}. The protein forms orthogonal arrays of particles (OAPs) in the plasma membrane that mediate rapid water flux between the cerebrospinal fluid (CSF) and interstitial fluid (ISF).

Structure

AQP4 exists as two major isoforms:

• M1 isoform (323 aa): Contains the full sequence, localizes to both astrocyte cell bodies and end-feet

• M23 isoform (323 aa): Truncated at the N-terminus, organizes into larger OAPs and is primarily end-foot localized

The protein forms tetramers that assemble into larger orthogonal arrays:

• Monomer: Six transmembrane alpha-helices with cytoplasmic N- and C-termini

• Tetramer: Four monomers form a functional water channel (~4 water molecules per nanosecond)

• OAP (Orthogonal Array of Particles): Multiple tetramers cluster to form large assemblies visible by freeze-fracture electron microscopy

The M23 isoform has a shorter N-terminus that lacks the palmitoylation sites present in M1, allowing more efficient OAP formation^{5AQP4 structure and assembly (1994)1994 · DOI 10.1126/science.7512454Open reference}.

Normal Function

Water Homeostasis

AQP4 mediates rapid water transport across the blood-brain barrier:

• Glymphatic clearance: CSF flows into the brain along perivascular spaces, then water exits through AQP4 into the interstitium

• Astrocyte volume regulation: AQP4 helps maintain optimal astrocyte hydration

• CSF-ISF exchange: Facilitates bidirectional water flow between fluid compartments

Potassium Buffering

AQP4 works with Kir4.1 potassium channels to buffer extracellular potassium:

• During neuronal activity, potassium is released into the extracellular space

• AQP4-mediated water flux helps disperse potassium

• Coordinated with Kir4.1 for efficient potassium clearance^{6Kofuji & Newman, AQP4 and Kir4.1 buffering (2009)2009 · PMID 19447094Open reference}

Neuroinflammation

AQP4 plays complex roles in neuroinflammation:

• Upregulated in reactive astrocytes surrounding lesions

• Involved in edema formation during inflammation

• Regulates immune cell trafficking across the BBB

Water Homeostasis in the Brain

AQP4 is the principal water channel in the central nervous system, critical for:

• Brain water balance: Regulating extracellular and intracellular water

• Cerebral edema resolution: Facilitating fluid clearance after injury

• K+ buffering: Supporting neuronal excitability regulation

• Metabolite transport: Enabling diffusion of small molecules

• Sleep regulation: Associated with glymphatic system function

The perivascular localization of AQP4 (at astrocyte end-feet) positions it ideally for:

• Rapid water flux between blood and brain

• Cerebrospinal fluid circulation

• Waste clearance via the glymphatic system

Role in Cerebral Edema

AQP4 plays a dual role in cerebral edema:

Cytotoxic edema (cell swelling):

• AQP4 facilitates water entry into astrocytes

• Loss of AQP4 reduces swelling in early phases

• Knockout mice show improved outcomes in some edema models

Vasogenic edema (vessel leakage):

• AQP4 helps clear interstitial fluid

• Enhanced AQP4 expression may worsen edema resolution

• Therapeutic modulation must consider edema type

Neuroinflammation and Disease

AQP4 dysfunction contributes to multiple neurological conditions:

• Multiple sclerosis: Altered expression in demyelinated lesions

• Epilepsy: Dysregulated AQP4 affects neuronal excitability

• Traumatic brain injury: Edema formation and resolution

• Stroke: Ischemic damage and reperfusion injury

• Alzheimer’s disease: Implicated in amyloid clearance

• Parkinson’s disease: May affect dopaminergic neuron survival

Therapeutic Modulation

Targeting AQP4 therapeutically includes:

1. AQP4 inhibitors: Reducing water flux in cytotoxic edema

2. AQP4 modulators: Altering channel gating

3. Gene therapy: Expressing modified AQP4 constructs

4. Combination approaches: AQP4 targeting with other therapies

5. Biomarkers: AQP4 autoantibodies in neuromyelitis optica

Role in Disease

Alzheimer’s Disease

AQP4 dysfunction significantly impacts AD pathogenesis:

• Impaired amyloid clearance: AQP4 deficiency reduces Aβ clearance by ~40%^{2Glymphatic clearance of Aβ (2012)2012 · DOI 10.1126/science.1220363Open reference}

• Perivascular AQP4 loss: Reduced AQP4 expression around cerebral vessels in AD patients

• Glymphatic impairment: Sleep-dependent Aβ clearance is AQP4-dependent

• Tau pathology: AQP4 dysfunction may exacerbate tau spread via glymphatic pathways

Parkinson’s Disease

AQP4 influences PD through multiple mechanisms:

• Alpha-synuclein clearance: Glymphatic system removes extracellular α-syn

• Impaired clearance in PD: Reduced AQP4 expression observed in PD models

• Blood-brain barrier leakage: AQP4 dysregulation contributes to BBB breakdown

• Neuroinflammation: AQP4 affects microglial activation states^{4AQP4 in Parkinson's disease (2018)2018 · PMID 29526542Open reference}

Stroke and Traumatic Brain Injury

AQP4 has dual roles in acute brain injury:

• Early phase: Contributes to cytotoxic edema (cell swelling)

• Late phase: Facilitates vasogenic edema resolution

• Therapeutic window: Modulating AQP4 can reduce injury if timed correctly

Multiple Sclerosis

AQP4 is the autoantigen in neuromyelitis optica (NMO):

• Autoantibodies against AQP4 cause demyelination

• Loss of AQP4 in lesion centers

• Astrocyte dysfunction precedes demyelination^{7AQP4 autoantibody in NMO (2005)2005 · DOI 10.1084/jem.20051903Open reference}

Therapeutic Implications

AQP4 represents a therapeutic target for several conditions:

• Glymphatic enhancement: Compounds that increase AQP4 expression or activity could improve waste clearance in AD/PD

• Sleep modulation: Optimizing sleep architecture enhances AQP4-mediated glymphatic clearance

• Anti-AQP4 antibodies: For NMO treatment, approaches to block pathogenic antibodies

• Edema management: AQP4 modulators for stroke and TBI

• Gene therapy: AAV-mediated AQP4 expression for neurodegenerative diseases^{8AQP4 as therapeutic target (2016)2016 · DOI 10.1016/j.tips.2016.04.013Open reference}

Interactions

AQP4 interacts with:

• Kir4.1 (KCNJ10): Potassium channel coordinate for potassium/water buffering

• Dystroglycan complex: Anchor at astrocyte end-feet

• Mitochondrial proteins: AQP4 localizes to some mitochondrial membranes

• Cytoskeletal proteins: Interaction with actin for membrane anchoring

Brain Atlas Resources

• Allen Human Brain Atlas - AQP4 Expression

• Allen Cell Type Atlas - AQP4

• BrainSpan - AQP4 Developmental Expression

• Allen Mouse Brain Atlas - AQP4

Pathway & Interaction Diagram

Interactive diagram showing AQP4’s key relationships in the SciDEX knowledge graph (15 connections shown).

flowchart TD
    AQP4(["AQP4"])
    NMOSD["NMOSD"]
    Glymphatic_System("Glymphatic System")
    Central_Nervous_System["Central Nervous System"]
    Neuromyelitis_Optica_Spectrum_Disorder["Neuromyelitis Optica Spectrum Di..."]
    Glymphatic_Pathway["Glymphatic Pathway"]
    Water_Flux("Water Flux")
    Sepsis_Associated_Encephalopathy["Sepsis-Associated Encephalopathy"]
    GLYMPHATIC_SYSTEM["GLYMPHATIC SYSTEM"]
    COMPLEMENT_CASCADE["COMPLEMENT CASCADE"]
    NEUROMYELITIS_OPTICA_SPECTRUM_DISORDER["NEUROMYELITIS OPTICA SPECTRUM DI..."]
    Neuromyelitis_Optica["Neuromyelitis Optica"]

    AQP4 -->|"biomarker for"| NMOSD
    AQP4 -->|"involved in"| Glymphatic_System
    AQP4 -->|"expressed in"| Central_Nervous_System
    AQP4 -->|"biomarker for"| Neuromyelitis_Optica_Spectrum_Disorder
    AQP4 -->|"involved in"| Glymphatic_Pathway
    AQP4 -->|"mediates"| Water_Flux
    AQP4 -->|"associated with"| Sepsis_Associated_Encephalopathy
    AQP4 -->|"associated with"| Glymphatic_System
    AQP4 -->|"involved in"| GLYMPHATIC_SYSTEM
    AQP4 -->|"activates"| COMPLEMENT_CASCADE
    AQP4 -->|"associated with"| NEUROMYELITIS_OPTICA_SPECTRUM_DISORDER
    AQP4 -->|"biomarker for"| NEUROMYELITIS_OPTICA_SPECTRUM_DISORDER
    AQP4 -->|"component of"| Glymphatic_System
    AQP4 -->|"biomarker for"| Neuromyelitis_Optica
    AQP4 -->|"associated with"| Neuromyelitis_Optica_Spectrum_Disorder

    style AQP4 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#fff

See Also

• AQP4 Gene

• Glymphatic System

• Astrocytes in Neurodegeneration

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• UniProt: P55064

• GeneCards: AQP4

• OMIM: 600030

• Allen Brain Atlas: AQP4 expression